Epoch Investment Partners Inc. increased its stake in HealthSouth Corp (NYSE:HLS) by 0.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 736,376 shares of the company’s stock after purchasing an additional 2,680 shares during the quarter. Epoch Investment Partners Inc. owned 0.75% of HealthSouth worth $34,131,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of HLS. Vanguard Group Inc. boosted its stake in shares of HealthSouth by 4.6% during the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock worth $364,571,000 after acquiring an additional 328,081 shares during the last quarter. William Blair Investment Management LLC boosted its stake in shares of HealthSouth by 13.9% during the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after acquiring an additional 525,767 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of HealthSouth by 0.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,035,977 shares of the company’s stock worth $186,946,000 after acquiring an additional 33,201 shares during the last quarter. State Street Corp boosted its stake in shares of HealthSouth by 7.5% during the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock worth $151,479,000 after acquiring an additional 219,306 shares during the last quarter. Finally, Voya Investment Management LLC boosted its stake in shares of HealthSouth by 4.4% during the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock worth $78,485,000 after acquiring an additional 68,486 shares during the last quarter. Institutional investors own 93.37% of the company’s stock.

Shares of HealthSouth Corp (HLS) traded down $0.85 during mid-day trading on Wednesday, hitting $48.79. 714,700 shares of the stock traded hands, compared to its average volume of 906,622. The company has a market cap of $4,880.15, a P/E ratio of 17.79, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54. HealthSouth Corp has a 12-month low of $38.24 and a 12-month high of $50.41. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89.

HealthSouth (NYSE:HLS) last announced its quarterly earnings data on Thursday, October 26th. The company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The firm had revenue of $995.60 million for the quarter, compared to the consensus estimate of $985.75 million. HealthSouth had a net margin of 6.69% and a return on equity of 22.81%. The company’s revenue was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $0.65 EPS. equities analysts expect that HealthSouth Corp will post 2.72 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a yield of 2.05%. HealthSouth’s dividend payout ratio is currently 36.36%.

Several research analysts have recently weighed in on HLS shares. Zacks Investment Research cut shares of HealthSouth from a “buy” rating to a “hold” rating in a research note on Tuesday, August 15th. Stephens assumed coverage on shares of HealthSouth in a research report on Thursday, August 31st. They set an “overweight” rating and a $53.00 price objective on the stock. ValuEngine downgraded shares of HealthSouth from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Royal Bank Of Canada restated a “buy” rating and set a $55.00 price objective on shares of HealthSouth in a research report on Wednesday, September 6th. Finally, KeyCorp restated a “hold” rating on shares of HealthSouth in a research report on Thursday, September 7th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $51.75.

In related news, Director Yvonne M. Curl purchased 1,000 shares of HealthSouth stock in a transaction on Wednesday, November 1st. The shares were bought at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the acquisition, the director now owns 64,144 shares in the company, valued at approximately $2,947,416.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Epoch Investment Partners Inc. Raises Position in HealthSouth Corp (HLS)” was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://theolympiareport.com/2017/12/06/epoch-investment-partners-inc-raises-position-in-healthsouth-corp-hls.html.

About HealthSouth

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.